the present historical paper concentrates on the roots of the pharmacodynamic concept of ca++ antagonism , and on the various therapeutic consequences of transmembrane ca++ entry inhibition , i.e. , normalization of hyperkinetic cardiac disorders , suppression of arterial and arteriolar spasms , relief of systemic arterial hypertension , stopping of cardiac dysrhythmias .
C0018799
of
C0003811
cardiac dysrhythmias